News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,926 Results
Type
Article (87493)
Company Profile (807)
Press Release (773603)
Multimedia
Podcasts (176)
Webinars (28)
Section
Business (233078)
Career Advice (4140)
Deals (39802)
Drug Delivery (138)
Drug Development (91271)
Employer Resources (203)
FDA (18292)
Job Trends (17404)
News (397450)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1687)
Antibody-drug conjugate (ADC) (257)
Approvals (18326)
Artificial intelligence (506)
Autoimmune disease (93)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (164)
Biotechnology (485)
Bladder cancer (137)
Brain cancer (53)
Breast cancer (514)
Cancer (4080)
Cardiovascular disease (354)
Career advice (3560)
Career pathing (38)
CAR-T (251)
CDC (57)
Cell therapy (698)
Cervical cancer (33)
Clinical research (75697)
Collaboration (1425)
Company closure (4)
Compensation (943)
Complete response letters (61)
COVID-19 (2961)
CRISPR (82)
C-suite (610)
Cystic fibrosis (140)
Data (4738)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (459)
Diagnostics (7101)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (241)
Drug pricing (193)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (98990)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133216)
Executive appointments (996)
FDA (20833)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1285)
Gene editing (175)
Generative AI (52)
Gene therapy (558)
GLP-1 (1027)
Government (5390)
Grass and pollen (7)
Guidances (364)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (247)
Immuno-oncology (21)
Indications (55)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (195)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (642)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (585)
Lymphoma (269)
Machine learning (32)
Management (66)
Manufacturing (655)
MASH (145)
Medical device (14898)
Medtech (14923)
Mergers & acquisitions (22769)
Metabolic disorders (1174)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (234)
Neuropsychiatric disorders (63)
Neuroscience (2745)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (565)
Opinion (315)
Ovarian cancer (138)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (30)
Patents (426)
Patient recruitment (329)
Peanut (57)
People (66317)
Pharmaceutical (145)
Pharmacy benefit managers (28)
Phase I (23349)
Phase II (32848)
Phase III (24769)
Pipeline (2788)
Policy (298)
Postmarket research (3554)
Preclinical (10535)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (692)
Real estate (7422)
Recruiting (79)
Regulatory (28086)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (139)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (96)
The Weekly (111)
Vaccines (1058)
Venture capital (67)
Weight loss (400)
Women's health (60)
Worklife (21)
Date
Today (173)
Last 7 days (763)
Last 30 days (2915)
Last 365 days (33525)
2025 (27462)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1281)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51031)
Australia (8971)
California (9668)
Canada (2901)
China (927)
Colorado (408)
Connecticut (431)
Delaware (277)
Europe (117254)
Florida (1424)
Georgia (319)
Hawaii (3)
Idaho (67)
Illinois (820)
India (54)
Indiana (479)
Iowa (20)
Japan (330)
Kansas (126)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1294)
Massachusetts (7243)
Michigan (317)
Minnesota (574)
Mississippi (4)
Missouri (123)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2685)
New Mexico (32)
New York (2622)
North Carolina (1426)
North Dakota (10)
Northern California (4414)
Ohio (304)
Oklahoma (22)
Oregon (51)
Pennsylvania (2007)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3687)
Tennessee (152)
Texas (1523)
United States (35646)
Utah (287)
Virginia (251)
Washington D.C. (84)
Washington State (830)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,926 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
October 29, 2025
·
5 min read
Press Releases
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
October 29, 2025
·
17 min read
Press Releases
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025
October 29, 2025
·
3 min read
Press Releases
Glaukos Announces Third Quarter 2025 Financial Results
October 29, 2025
·
17 min read
Press Releases
Savara Announces Proposed Public Offering
October 29, 2025
·
5 min read
Press Releases
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform
October 29, 2025
·
8 min read
Press Releases
Bio-Rad Reports Third-Quarter 2025 Financial Results
October 29, 2025
·
21 min read
Press Releases
Microbiome Labs Expands Portfolio with Launch of Women’s Health Line
October 29, 2025
·
2 min read
Biosimilars
FDA Proposes Lower Bar for Biosimilar Approvals in Bid To Lower Drug Prices
Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, HHS leaders said while announcing new draft guidance.
October 29, 2025
·
3 min read
·
Dan Samorodnitsky
Immunology and inflammation
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment
Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in Sjögren’s disease, the pharma reported at the American College of Rheumatology Convergence congress on Wednesday.
October 29, 2025
·
3 min read
·
Heather McKenzie
1 of 86,193
Next
